和铂医药-B10月17日斥资513.49万港元回购40万股
HBM HOLDINGSHBM HOLDINGS(HK:02142) Zhi Tong Cai Jing·2025-10-17 11:04

Core Viewpoint - The company, Heptagon Pharmaceuticals-B (02142), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will repurchase 400,000 shares at a total cost of HKD 5.1349 million [1]